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  Upon entering a cell, a virus often 
becomes dormant, turning off its genes 
and laying low until awakened by some 
trigger from its environment. When 
that trigger is pulled, the virus quickly 
ramps up production of proteins 
through built-in positive-feedback 
loops that turn up gene transcription. 
(In positive feedback, production of 
something stimulates more production 
of that thing, resulting in exponential, 
or faster, growth.)
    If the viral environment were 
perfectly regulated and viral gene 
expression perfectly silenced during 
latency, this system would be foolproof. 
But this is almost never the case—there 
is always noise and always the potential 
for some low level of erroneous 
transcription. This poses a problem for 
the virus—how does it prevent stray 
transcription from erupting into full-
blown activation?
    Certain bacterial viruses manage 
this problem by encoding intricate 
repressor circuits that efﬁ  ciently block 
transcription. But animal viruses, 
speciﬁ  cally HIV, appear to lack similar 
repressor circuits. In a new study, 
Leor Weinberger and Thomas Shenk 
propose that some animal viruses, 
including HIV, regulate their potential 
for positive feedback and maintain 
latency by successively modifying 
and dissipating, or introducing a 
resistor into, the main activator of 
transcription.
    HIV’s transcriptional activator, 
the   Tat   gene, is encoded in the HIV 
genome. Once   Tat   is transcribed, it 
can rapidly increase transcription 
not only of itself, but also of other 
genes that ultimately lead to viral 
replication. Thus, the Tat protein acts 
like a molecular switch, making it a 
likely target for regulating latency. In 
some kinds of molecular switches, the 
conversion between on and off states 
is regulated by self-oligomerization, 
or binding to several other identical 
molecules. The shape changes induced 
by binding or unbinding drive the 
complex into two different stable 
conformations. But, the authors 
found no experimental evidence 
for oligomerization of Tat; instead, 
both on and off forms appear to be 
monomers. 
    Other studies have shown that Tat 
is activated by the addition of an acetyl 
group—a functional group that is 
frequently added to (acetylation) or 
removed from (deacetylation) proteins 
to modify their properties—and that 
deacetylation inactivates Tat. Based on 
the known kinetics of both acetylation 
and deacetylation, the authors 
postulated that a resistor might exist in 
the Tat circuit. A simple mathematical 
model showed that the interconversion 
of the two forms, coupled with the 
known rate of breakdown of Tat, was 
sufﬁ  cient to encode a resistor that 
explained Tat circuit shutoff and 
possibly the stability of HIV’s latent state. 
    In the Tat resistor model, as in 
the cell, Tat deacetylation occurs at 
a much faster rate than acetylation. 
Deacetylated (inactive) Tat can take 
one of two paths—reconversion into 
acetylated (active) Tat, or destruction 
of the protein by cellular machinery. 
When the appropriate conversion and 
destruction rates were fed into their 
model, activated Tat appeared brieﬂ  y 
after a stray burst of transcription but 
quickly disappeared without breaking 
viral latency. This prediction of the 
model was then precisely replicated in 
cell culture experiments. An array of 
cell culture experiments perturbing 
the supposed Tat resistor was then 
performed. For example, inhibition 
of the deacetylating enzyme SirT1 
induced Tat transcription activation 
in cells, further supporting the role 
of Tat acetylation in controlling viral 
dormancy. Finally, simulations under 
noisy conditions predicted that this 
simple resistor system was better able 
to resist environmental ﬂ  uctuations 
than hypothetical oligomer-dependent 
switches, and cell-sorting experiments 
conﬁ  rmed this prediction.
    This simple switch, in which the 
deactivating reaction overpowers 
the activating reaction under most 
circumstances, acts as a “feedback 
resistor,” and its general features, the 
authors suggest, are likely to be found in 
other systems that must rapidly alternate 
between two states while resisting noise 
in the environment. Their model 
may also provide an explanation for 
some puzzling observations about Tat 
and HIV. Tat contains at least two 
acetylation sites that must both be 
deacetylated to turn off transcription. 
The authors propose this requirement 
may avoid making the off state so easy to 
reach that the virus remains dormant all 
the time. This model also helps explain 
why some HIV patients experience 
short “blips” of viral activity, despite 
relatively low viral concentration. 
According to the authors, these pulses 
of viral activation may be due either to 
random increases of Tat activity or to 
environmental inhibitors of the SirT1 
enzyme, such as dihydrocoumarin, a 
natural ﬂ  avoring agent found in clover.
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  HIV Tat transactivates its own expression, 
but this requires conversion from 
deacetylated Tat (TatD) to acetylated 
Tat (TatA), a reaction that establishes a 
feedback resistor and allows the circuit to 
shut off. 